Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Apr;1281(1):92-105.
doi: 10.1111/nyas.12031. Epub 2013 Jan 30.

Islet β cell mass in diabetes and how it relates to function, birth, and death

Gordon C Weir  1 , Susan Bonner-Weir
Affiliations
Free PMC article
Review

Islet β cell mass in diabetes and how it relates to function, birth, and death

Gordon C Weir et al. Ann N Y Acad Sci. 2013 Apr.
Free PMC article

Abstract

In type 1 diabetes (T1D) β cell mass is markedly reduced by autoimmunity. Type 2 diabetes (T2D) results from inadequate β cell mass and function that can no longer compensate for insulin resistance. The reduction of β cell mass in T2D may result from increased cell death and/or inadequate birth through replication and neogenesis. Reduction in mass allows glucose levels to rise, which places β cells in an unfamiliar hyperglycemic environment, leading to marked changes in their phenotype and a dramatic loss of glucose-stimulated insulin secretion (GSIS), which worsens as glucose levels climb. Toxic effects of glucose on β cells (glucotoxicity) appear to be the culprit. This dysfunctional insulin secretion can be reversed when glucose levels are lowered by treatment, a finding with therapeutic significance. Restoration of β cell mass in both types of diabetes could be accomplished by either β cell regeneration or transplantation. Learning more about the relationships between β cell mass, turnover, and function and finding ways to restore β cell mass are among the most urgent priorities for diabetes research.

PubMed Disclaimer

Figures

Figure 1
Figure 1
β cell relative volume in autopsy pancreases from individuals who were nondiabetic (ND) had impaired fasting glucose (IFTG) or had type 2 diabetes mellitus (TTDM). Figure taken from Ref. , with permission from the American Diabetes Association.
Figure 2
Figure 2
Increments of acute GSIS in subjects with increasing fasting plasma glucose levels. Figure taken from Ref. , with permission from the Endocrine Society.
Figure 3
Figure 3
Subjects with noninsulin-dependent diabetes (NIDDM, T2D) and control subjects whose glucose levels were increased with glucose infusions followed by acute stimulation of insulin secretion with intravenous arginine. Figure taken from Ref. , with permission from the Endocrine Society.
Figure 4
Figure 4
Section of pancreas (20× magnification) stained for insulin. Numerous pancreatic ducts are shown, with insulin-positive cells present in and next to duct wall, suggesting new islet formation from exocrine ducts (neogenesis). Figure taken from Ref. , with permission from the American Diabetes Association.
See this image and copyright information in PMC

References

    1. Maclean N, Ogilvie RF. Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes. 1955;4:367–376. - PubMed
    1. Butler AE, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–110. - PubMed
    1. Yoon KH, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J. Clin. Endocrinol. Metab. 2003;88:2300–2308. - PubMed
    1. Rahier J, et al. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes. Metab. 2008;10(Suppl 4):32–42. - PubMed
    1. Kloppel G, et al. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv. Synth. Pathol. Res. 1985;4:110–125. - PubMed

Publication types

MeSH terms